Home
About
Overview
Sharing Data
ORCID
Help
History (33)
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2.
What Chicago community organizations needed to implement COVID-19 interventions: lessons learned in 2021.
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer.
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.
See All 33 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password